Your browser doesn't support javascript.
loading
DNAM-1-chimeric receptor-engineered NK cells, combined with Nutlin-3a, more effectively fight neuroblastoma cells in vitro: a proof-of-concept study.
Focaccetti, Chiara; Benvenuto, Monica; Pighi, Chiara; Vitelli, Alessandra; Napolitano, Federico; Cotugno, Nicola; Fruci, Doriana; Palma, Paolo; Rossi, Paolo; Bei, Roberto; Cifaldi, Loredana.
Afiliación
  • Focaccetti C; Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.
  • Benvenuto M; Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.
  • Pighi C; Saint Camillus International University of Health and Medical Sciences, Rome, Italy.
  • Vitelli A; Research Unit of Clinical Immunology and Vaccinology, Dipartimento Pediatrico Universitario Ospedaliero (DPUO), Ospedale Pediatrico Bambino Gesù, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
  • Napolitano F; ReiThera Srl, Rome, Italy.
  • Cotugno N; ReiThera Srl, Rome, Italy.
  • Fruci D; Research Unit of Clinical Immunology and Vaccinology, Dipartimento Pediatrico Universitario Ospedaliero (DPUO), Ospedale Pediatrico Bambino Gesù, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
  • Palma P; Chair of Pediatrics, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.
  • Rossi P; Department of Paediatric Haematology/Oncology and of Cell and Gene Therapy, Ospedale Pediatrico Bambino Gesù, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
  • Bei R; Research Unit of Clinical Immunology and Vaccinology, Dipartimento Pediatrico Universitario Ospedaliero (DPUO), Ospedale Pediatrico Bambino Gesù, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
  • Cifaldi L; Chair of Pediatrics, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.
Front Immunol ; 13: 886319, 2022.
Article en En | MEDLINE | ID: mdl-35967339
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteína p53 Supresora de Tumor / Neuroblastoma Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteína p53 Supresora de Tumor / Neuroblastoma Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Italia